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Ⅰ．Introduction
 Human parechovirus （HPeV） infection is commonly 
associated with mild respiratory or gastrointestinal 
symptoms in young children［1］. However, in HPeV-
3 infection particularly, severe outcomes such as 
sepsis-like illness, meningoencephalitis, and paralysis 
have been reported in neonates and young infants［2-
5］. In addition, hemophagocytic lymphohistiocytosis 
associated with HPeV-3 infection has been reported
［6,7］. Hyperferritinemia is observed in these patients
［8］, suggesting that cytokine storm might play a 
significant role, but this remains unproven.
 Here, we report 2 infants with systemic inflammatory 
response syndrome caused by HPeV-3 infection in 
whom serum levels of multiple inflammatory cytokines 
were evaluated. We discuss the findings in relation to 
cytokine storm involvement in the pathophysiology of 
HPeV-3 infection. 
Ⅱ．Cases
 Two infants were diagnosed with HPeV-3 infection 
by polymerase chain reaction （PCR） assay of their nasal 
swab, stool, and cerebrospinal fluid （CSF） samples. 
Both patients were born at term with no perinatal 
abnormalities. On admission, both infants met criteria 
for pediatric systemic inflammatory response syndrome
［9］（Table 1）. 
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Abstract
Severe outcomes such as sepsis-like illness, meningoencephalitis, and hemophagocytic 
lymphohistiocytosis have been reported in neonates and young infants with human 
parechovirus-3 （HPeV-3） infection, suggesting a possible significant role for cytokine storm in 
this infection. However, this remains unproven. In this report, we describe the inflammatory 
cytokine profiles in serum samples of 2 infants with HPeV-3 infection with systemic 
inflammatory response syndrome that were investigated using cytokine multiplex assay. Both 
infants had elevated serum levels of several cytokines, particularly MCP-1, IL-6, IL-10, and 
TNF-α. These results could provide direct evidence for the involvement of cytokine storm in the 
pathophysiology of HPeV-3 infection.
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 Patient 1 was a previously healthy male infant aged 
2 months with fever, groaning, and cyanosis. He was 
admitted to the pediatric intensive care unit and treated 
with antibiotics （ampicillin and cefotaxime） for 5 days 
until confirmatory negative results were obtained from 
bacterial cultures of urine, nasopharyngeal swab, blood, 
and CSF （cell count /μL）. HPeV-3 was detected in 
stool. He was discharged 6 days after admission with no 
residual complications.
 Patient 2 was an 8-day-old female neonate. At 4 
days after discharge from the maternity hospital, she 
developed fever, impaired suckling, groaning, and 
cyanosis. HPeV-3 was detected in stool and CSF. 
She was treated with ampicillin and cefotaxime for 5 
days, until confirmatory negative results were obtained 
for bacterial cultures of urine, nasopharyngeal swab, 
blood, and CSF （cell count was unknown because of 
blood contamination）. She was discharged 8 days after 
admission with no residual complications.
 For the diagnosis of HPeV infection, nasopharyngeal 
swab, stool, and CSF samples were collected from 
each patient and stored at －80℃ until nucleic acid 
extraction. Nucleic acid was extracted using the High 
Pure Viral Nucleic Acid Kit （Roche Diagnostics Corp., 
Mannheim, Germany） according to the manufacturer’s 
instructions. Then, reverse transcription （RT）-PCR was 
performed using previously described methods with 
slight modifications［10］. Briefly, a superscript one-
step RT-PCR system （Invitrogen Corp., Carlsbad, CA, 
USA） was used for reverse-transcription and first-round 
PCR with virus-specific primers per the manufacturer’s 
instructions. Each sample was examined for HPeV and 
enterovirus. Following amplification, PCR products 
were separated on a 1.5% agarose gel with Tris-Boric 
acid-EDTA buffer and visualized with SYBR-green 
（Cambrex Corp., Rockland, ME, USA） under a UV 
trans-illuminator. PCR products were purified and the 
nucleic acid sequences were determined. The nucleotide 
sequences were processed using GENETYX software 
and compared with nucleotide sequences on the DNA 
database using the BLAST system （https://blast.ncbi.
nlm.nih.gov/Blast.cgi）.
 For serum cytokine measurement, blood samples 
were obtained from both patients at admission. Serum 
samples were frozen and stored at －80℃ until 
measurement of cytokine levels. All samples were 
measured on the same plate at the same time using 
the Bio-Plex Pro multiple cytokine measurement kit 
（Bio-Rad Laboratories Inc., Hercules, CA, USA） 
following the manufacturer’s instructions. Cytokines 
that were measured included IL-1β, IL-2, IL-4, IL-
5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 （p70）, IL-
13, IL-17, granulocyte colony-stimulating factor, 
interferon （IFN）-γ, monocyte chemoattractant protein 
（MCP）-1, tumor necrosis factor （TNF）-α, and vascular 
endothelial growth factor［10］. Previously, we used 
this measurement system to evaluate serum samples of 
healthy children （median age 12 ［range 4-21］ months）, 
and we used the results as normal controls for infants 
and young children［10］.
 Results of cytokine assay are shown in Table 2. 
Serum levels for 13 of 17 cytokines in both patients 
were higher than the maximum level in normal controls. 
Specifically, levels of MCP-1 were more than 20 times 
higher than the maximum level in controls （695 and 
812 vs 28.9 pg/mL）. In addition, both inflammatory 
cytokines （IL-6: 52.8 and 59.2 vs 8.2 pg/mL, TNF-α: 
Table 1　Patient characteristics
　 　 Patient 1 Patient 2
Age （days） 68 8 
Sex Male Female
Max. body temp. （℃） 38.9 38.7
Heart rate at 
presentation
（bpm） 227 180
Respiratory rate （/min） 38 42
Symptom 　 　 　
Cyanosis ＋ ＋
Groaning 　 ＋ ＋
HPeV-3 detection from 　 　
Nasopharyngeal swab － －
Stool 　 ＋ ＋
Cerebrospinal fluid － ＋
Blood tests 　 　
CRP （mg/dL） 0.70 0.19
WBC （×103/µL） 6.49 15.61
PLT （×104/µL） 44.9 29.7
AST （IU/L） 87 29
LDH （IU/L） 349 423
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126 and 78.1 vs 16.7 pg/mL） and anti-inflammatory 
cytokines （IL-10: 77.6 and 44.8 vs 6.7 pg/mL） were 
remarkably increased in both patients compared with 
controls （Table 2）.
Ⅲ．Discussion
 Yuzurihara et al.［6］reported that the characteristic 
laboratory findings of patients with HPeV-3 infection 
were elevated levels of serum aspartate aminotransferase 
（AST）, lactate dehydrogenase, fibrin degradation, 
D-dimer, and ferritin, suggesting that organ damage was 
a result of hypercytokinemia-induced systemic cellular 
activation. Aviner et al.［7］described an infant with 
hemophagocytic lymphohistiocytosis associated with 
HPeV-3 meningitis. Serum levels of AST, D-dimer, 
fibrinogen, and ferritin were extremely high［7］. 
Hyperferritinemia was also reported in 6 patients with 
HPeV-3 infection complicated by enterovirus infection
［8］. Results in our cases show direct evidence of 
hypercytokinemia, consistent with the findings of these 
previous reports.
 We previously reported serum cytokine levels in 
patients with respiratory syncytial virus （RSV） lower 
respiratory tract infection, a common viral respiratory 
infection in infants［10］. RSV infection is also a 
common febrile illness in children, but IL-1β, IL-5, 
IL-6, IL-7, IL-12 （P70）, IL-13, IL-17, IFN-γ, MCP-
1, and TNF-α levels in the 2 infants were also found 
to be high compared with levels in patients with RSV 
infection［10］, suggesting cytokine storm with elevated 
levels of various inflammatory cytokines in systemic 
circulation. Overall, our data suggest that several 
inflammatory pathways can contribute to severe sepsis-
like conditions in neonates and infants.
 Recently, the serum cytokine profile of HPeV-
3 infection was reported for the first time. Shimizu et 
al.［11］measured serum levels of cytokines－IL-6, 
neopterin, IL-18, solube forms of tumor necrosis factor 
receptor types I （sTNFR-I） and II （sTNFR-II）－
in 12 patients with sepsis-like symptoms at the 
onset, peak, and recovery phases. They concluded 
that proinflammatory cytokines,  in particular, 
IFN-γ, TNF-α, and IL-18, are closely related to the 
development of HPeV3-induced sepsis-like syndrome. 
In both our cases, comprehensive evaluation of the 
laboratory data obtained from samples taken at a single 
timepoint in the early stage of the disease detected 17 
Table 2　Cytokine concentration in the serum of the 2 infants with HPeV3 infection
　 　
Patient 1 Patient 2
Control* Lower limit 
　 　 Median （min-max） Quantified**
IL-1β （pg/mL） 9.2 6.1 2.0 （0.8-2.4） 0.8
IL-2 （pg/mL） 26.1 12.4 1.6 （1.6-19.3） 1.6
IL-4 （pg/mL） 12.3 8.7 8.6 （4.6-10.4） 0.1
IL-5 （pg/mL） 12 7.1 2.2 （1.0-3.4） 0.7
IL-6 （pg/mL） 52.8 59.2 6.4 （3.8-8.2） 0.6
IL-7 （pg/mL） 48.7 29.8 10.3 （5.3-15.4） 0.7
IL-8 （pg/mL） 77.5 50.6 12.5 （8.6-20.8） 0.6
IL-9 （pg/mL） 64.0 31.9 20.7 （14.3-135） 2.5
IL-10 （pg/mL） 77.6 44.8 4.4 （1.9-6.7） 0.6
IL-12 （p70） （pg/mL） 249 119 30.0 （9.2-88.9） 3.5
IL-13 （pg/mL） 42.3 21.0 5.5 （2.3-9.1） 0.9
IL-17 （pg/mL） 276 139 49.6 （14.1-66.4） 8.7
G-CSF （pg/mL） 94.8 69.6 23.7 （17.9-29.2） 2.8
IFN-γ （pg/mL） 547 342 63.7 （37.3-151） 36.8
MCP-1 （pg/mL） 696 812 19.0 （9.9-28.9） 2.0 
TNF-α （pg/mL） 126 78.1 7.6 （7.6-16.7） 7.6
VEGF （pg/mL） 412 192 88.3 （27.8-219） 0.8
* Data from reference 10
** Data from manufacturer’s instructions
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